Continued medical treatment for persistent early endometrial cancer in young women.
CONCLUSIONS: Continued medical treatment is effective for persistent early endometrial carcinoma after at least 9 months of progestin therapy in young women who want to preserve their fertility.
PMID: 33246662 [PubMed - as supplied by publisher]
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Cho A, Lee SW, Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT Tags: Gynecol Oncol Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Endometrial Cancer | Endometrioid Carcinoma | Hormones | OBGYN | Ovarian Cancer | Ovaries | Reproduction Medicine | Science | Women